These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 29564387)
21. Tau PET Imaging in Neurodegenerative Disorders. Groot C; Villeneuve S; Smith R; Hansson O; Ossenkoppele R J Nucl Med; 2022 Jun; 63(Suppl 1):20S-26S. PubMed ID: 35649647 [TBL] [Abstract][Full Text] [Related]
22. Imaging Protein Misfolding in the Brain Using β-Sheet Ligands. Harada R; Okamura N; Furumoto S; Yanai K Front Neurosci; 2018; 12():585. PubMed ID: 30186106 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
24. Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease. Ossenkoppele R; Hansson O Alzheimers Dement; 2021 Dec; 17(12):1998-2008. PubMed ID: 33984177 [TBL] [Abstract][Full Text] [Related]
25. Tau-PET imaging as a molecular modality for Alzheimer's disease. Ayubcha C; Rigney G; Borja AJ; Werner T; Alavi A Am J Nucl Med Mol Imaging; 2021; 11(5):374-386. PubMed ID: 34754608 [TBL] [Abstract][Full Text] [Related]
26. Higher plasma β-synuclein indicates early synaptic degeneration in Alzheimer's disease. Oeckl P; Janelidze S; Halbgebauer S; Stomrud E; Palmqvist S; Otto M; Hansson O Alzheimers Dement; 2023 Nov; 19(11):5095-5102. PubMed ID: 37186338 [TBL] [Abstract][Full Text] [Related]
27. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies. Thal DR; Attems J; Ewers M J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313 [TBL] [Abstract][Full Text] [Related]
28. Advances in the development of tau PET radiotracers and their clinical applications. Okamura N; Harada R; Furukawa K; Furumoto S; Tago T; Yanai K; Arai H; Kudo Y Ageing Res Rev; 2016 Sep; 30():107-13. PubMed ID: 26802556 [TBL] [Abstract][Full Text] [Related]
29. Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers. Shah M; Catafau AM J Nucl Med; 2014 Jun; 55(6):871-4. PubMed ID: 24833492 [TBL] [Abstract][Full Text] [Related]
30. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956 [TBL] [Abstract][Full Text] [Related]
31. Imaging of Reactive Astrogliosis by Positron Emission Tomography. Harada R; Furumoto S; Kudo Y; Yanai K; Villemagne VL; Okamura N Front Neurosci; 2022; 16():807435. PubMed ID: 35210989 [TBL] [Abstract][Full Text] [Related]
32. Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia. Ni R; Nitsch RM Front Aging Neurosci; 2021; 13():751897. PubMed ID: 35046791 [TBL] [Abstract][Full Text] [Related]
33. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA; Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397 [TBL] [Abstract][Full Text] [Related]
34. The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders. Irwin DJ; Hurtig HI J Alzheimers Dis Parkinsonism; 2018; 8(4):. PubMed ID: 30473927 [TBL] [Abstract][Full Text] [Related]
35. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients. Ho CY; Troncoso JC; Knox D; Stark W; Eberhart CG Brain Pathol; 2014 Jan; 24(1):25-32. PubMed ID: 23714377 [TBL] [Abstract][Full Text] [Related]
36. Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque. Holland JP; Liang SH; Rotstein BH; Collier TL; Stephenson NA; Greguric I; Vasdev N J Labelled Comp Radiopharm; 2014 Apr; 57(4):323-31. PubMed ID: 24327420 [TBL] [Abstract][Full Text] [Related]
37. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue. Lemoine L; Ledreux A; Mufson EJ; Perez SE; Simic G; Doran E; Lott I; Carroll S; Bharani K; Thomas S; Gilmore A; Hamlett ED; Nordberg A; Granholm AC Mol Neurodegener; 2020 Nov; 15(1):68. PubMed ID: 33222700 [TBL] [Abstract][Full Text] [Related]
38. Early detection of amyloid load using Bullich S; Roé-Vellvé N; Marquié M; Landau SM; Barthel H; Villemagne VL; Sanabria Á; Tartari JP; Sotolongo-Grau O; Doré V; Koglin N; Müller A; Perrotin A; Jovalekic A; De Santi S; Tárraga L; Stephens AW; Rowe CC; Sabri O; Seibyl JP; Boada M Alzheimers Res Ther; 2021 Mar; 13(1):67. PubMed ID: 33773598 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of tau deposition using Bullich S; Mueller A; De Santi S; Koglin N; Krause S; Kaplow J; Kanekiyo M; Roé-Vellvé N; Perrotin A; Jovalekic A; Scott D; Gee M; Stephens A; Irizarry M Alzheimers Res Ther; 2022 Jul; 14(1):105. PubMed ID: 35897078 [TBL] [Abstract][Full Text] [Related]
40. Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective. Ricci M; Cimini A; Camedda R; Chiaravalloti A; Schillaci O Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]